Per the AP, the policy would give pharmacies cover to make peptides that FDA staff scientists say lack safety and efficacy data. CSPI is pushing back hard.
Recap by typeshit. Full story at Ars Technica.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
The Telangana Drugs Control Administration issued a strict warning over unapproved weight-loss drugs and peptides being sold online in the Indian state.
Researchers at an autoimmune community gathering discussed how GLP-1 drugs are shifting thinking about health beyond the scale. Details are thin.
The interim policy, reported by AP, would shield some pharmacies from enforcement over restricted peptides. FDA had flagged risks like contamination and tumor growth.
Loading…